We are live on ! Find out more
WINT

Windtree Therapeutics Inc
WINT

Delisted

WINT was delisted on the 4th of May, 2017.

Back to rankings

26 hedge funds and large institutions have $2.63M invested in Windtree Therapeutics Inc in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% less funds holding

Funds holding: 31 → 26 (-5)

18% less capital invested

Capital invested by funds: $3.2M → $2.63M (-$573K)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

75% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 8

Holders
26
Holders Change
-5
Holders Change %
-16.13%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
8
Closed
5
Calls
$870K
Puts
–
Net Calls
+$870K
Net Calls Change
+$546K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$255K
2
Northern Trust
Northern Trust
Illinois
+$21.1K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$11K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$187

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$278K
2
SM
Sabby Management
Florida
-$60.9K
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$7.02K
4
AIM
Acrospire Investment Management
Illinois
-$6K
5
Group One Trading
Group One Trading
Illinois
-$4.01K
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Broadfin Capital
New York
$887K – – –
Alyeska Investment Group
2
Alyeska Investment Group
Illinois
$524K -$7.02K -5,405 -1%
SM
3
Sabby Management
Florida
$328K -$60.9K -46,892 -14%
BBA
4
Baker Bros. Advisors
New York
$291K – – –
BlackRock
5
BlackRock
New York
$224K +$255K +196,091 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$173K +$11K +8,500 +6%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$62K +$187 +144 +0.3%
Deutsche Bank
8
Deutsche Bank
Germany
$49K – – –
Northern Trust
9
Northern Trust
Illinois
$19K +$21.1K +16,209 New
ARTA
10
A.R.T. Advisors
New York
$16K -$2.73K -2,100 -13%
SFWA
11
Summit Financial Wealth Advisors
Louisiana
$15K – – –
California Public Employees Retirement System
12
California Public Employees Retirement System
California
$14K – – –
WS
13
Wedbush Securities
California
$12K – – –
UBS Group
14
UBS Group
Switzerland
$10K -$3.04K -2,340 -22%
Morgan Stanley
15
Morgan Stanley
New York
$5K -$40 -31 -0.8%
FDCDDQ
16
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.11K +$1.27K +978 New
Bank of America
17
Bank of America
North Carolina
$1K – – –
MPWT
18
MassMutual Private Wealth & Trust
Connecticut
$23 – – –
Fidelity Investments
19
Fidelity Investments
Massachusetts
– -$278K -224,091 Closed
AIM
20
Acrospire Investment Management
Illinois
– -$6K -4,800 Closed
Group One Trading
21
Group One Trading
Illinois
– -$4.01K -3,086 Closed
Creative Planning
22
Creative Planning
Kansas
– -$1.3K -1,000 -100%
TRCT
23
Tower Research Capital (TRC)
New York
– -$1K -664 Closed
LTFS
24
Ladenburg Thalmann Financial Services
Florida
– -$184 -142 -83%
Wells Fargo
25
Wells Fargo
California
– -$83 -64 -94%

WINT Hedge Fund Activity: Q1 2017 in Review

26 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q1 2017, worth a combined $2.63M — down 18% from $3.2M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of WINT and 3 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 2 added.

The largest buyer was BlackRock, opening a new position worth an estimated $255K. The largest seller was Fidelity Investments, exiting entirely with an estimated $278K sold.

  • 26 institutional investors held Windtree Therapeutics Inc (WINT) as of Q1 2017, down from 31 in Q4 2016.
  • Funds reported $2.63M of Windtree Therapeutics Inc stock for Q1 2017, down 18% quarter-over-quarter.
  • 3 funds opened new Windtree Therapeutics Inc positions in Q1 2017 and 5 closed out, a net change of -2 holders.
  • The largest Windtree Therapeutics Inc buyer in Q1 2017 was BlackRock, an estimated $255K added.
  • The largest Windtree Therapeutics Inc seller in Q1 2017 was Fidelity Investments, an estimated $278K sold.

Based on aggregated 13F filings for Q1 2017.